1. Zhang Y#, Dong Q#, Bian X#, Qiao Z, Cui C, Yang N, Liu J, Fu R, Zhang J, Jia L, Wu C, Guo J, Lin W, Wang J, Fan J, Li Y, Liu F, Yang B, Jia X, Gao C, Bai M, He Y, Han C, Yin D*, Dou K*. Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion. Cardiovasc Res. 2025. Epub 20251112. doi: 10.1093/cvr/cvaf223. (IF=13.3)
2. Zhang R#, Wu S#, Liu Q#, Guan C, Wang HY, Yuan S, Xie L, Huang Y, Qiao Z, Liu W, Fu R, Feng L, Zhu C, Song L, Yin D*, Dou K*. Functional Complete Revascularization as Determined by an Optimized Scoring System After Revascularization: A Post Hoc Analysis from Multi-Center PANDA III Trial. Adv Sci (Weinh). 2025;12(14):e2415961. Epub 20250218. doi: 10.1002/advs.202415961. (IF=14.1)
3. Zhang R#, Wang HY#, Song L*, Guan C, Yin D, Zhu C, Feng L, Jin Z, Yu B, Fu G, Zhou Y, Wang J, Chen Y, Pu J, Chen L, Qu X, Zhao Y, Wang Y, Liu W, Qiao S, Tu S, Wijns W, Dou K*. Rationales Behind Physiology-Guided Revascularization: Diagnostic Impact of Quantitative Flow Ratio in the FAVOR III China Trial. JACC Cardiovasc Interv. 2025. Epub 20251120. doi: 10.1016/j.jcin.2025.10.042. (IF=11.4)
4. Yao Z, Bai L, Dou K*, Nie Y*. Identifying Cardiomyocyte Ploidy With Nuclear Area and Volume. Circulation. 2024;149(19):1540-1542. (IF=37.8)
5. Wang HY#, Zhang R#, Dou K*, Huang Y, Xie L, Qiao Z, Zou T, Guan C, Song L, Yang W, Wu Y, Tu S, Wijns W, Xu B*. Left main bifurcation stenting: impact of residual ischaemia on cardiovascular mortality. Eur Heart J. 2023;44(41):4324-4336. (IF=39.3)
6. Song Y#, Zhu C#, Shi B#, Song C, Cui K, Chang Z, Gao G, Jia L, Fu R, Dong Q, Feng L, Zhu C, Yin D, Manson JE, Dou K*. Social isolation, loneliness, and incident type 2 diabetes mellitus: results from two large prospective cohorts in Europe and East Asia and Mendelian randomization. EClinicalMedicine. 2023;64:102236. (IF=15.1)
7. Zhang R#, Wang HY#, Dou K*, Yin D, Zhu C, Feng L, Zhou Y, Pu J, Zhang Q, Pan H, Mi J, Ye F, Cheng X, Guo N, Guan C, Song L, Qiao S, Tu S, Xu B*, Stone GW; FAVOR III China Study Group. Outcomes of Functionally Complete vs Incomplete Revascularization: Insights From the FAVOR III China Trial. JACC Cardiovasc Interv. 2022 Dec 26;15(24):2490-2502. (IF=11.20)
8. Wang HY#, Xu B*, Dou K*, Guan C, Song L, Huang Y, Zhang R, Xie L, Zhang M, Yan H, Yang W, Wu Y, Yang Y, Qiao S, Gao R, Stone GW. Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI. JACC Cardiovasc Interv. 2021 Aug 9;14(15):1623-1634. (IF=11.07)
9. Dou K#*, Zhang D#, Pan H, Guo N, Li L, Li Y, Zhang Q, Liu B, Shen Z, Zhang B, Liu J, Han W, Wang Y, Zhao Y, Yang Y, Chen S, Xie L, Guan C, Ajay J. Kirtane, Xu B*. Active Side Branch Protection Versus Conventional Approach to the Protection of High-Risk Side Branches--The CIT-RESOLVE Trial. JACC Cardiovasc Interv.2020 May 11;13(9):1112-1122. (IF=8.43, R)
10. Sun Y#, Chen YH, Li YY, Li ZZ, Li CZ, Yu T, Xiao L, Yu B, Zhao H, Tao M, Jiang JG, Yan JT, Wang Y, Zeng HS, Shen XQ, Zhou YW, Jin L, Song WH, Dou K*, Wang DW*. Association of TSR1 Variants and Spontaneous Coronary Artery Dissection. J Am Coll Cardiol. 2019 Jul 16;74(2):167-176. (IF=18.64)